COX3 Antibody [Janelia Fluor® 646]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-97594JF646
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin
Label
Janelia Fluor 646
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for COX3 Antibody [Janelia Fluor® 646]
Immunogen
Produced in rabbits immunized with E. coli-derived Human COX3 fragment.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for COX3 Antibody [Janelia Fluor® 646]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: COX3
Alternate Names
COIII, COX3, MTCO3, MT-CO3, MT-CO3 mitochondrially encoded cytochrome c oxidase III
Gene Symbol
COX3
Additional COX3 Products
Product Documents for COX3 Antibody [Janelia Fluor® 646]
Product Specific Notices for COX3 Antibody [Janelia Fluor® 646]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...